Geneva Advisors’s Alkermes ALKS Stock Holding History

Geneva Advisors’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-43,126	Closed	-$1.9M	–	715
2014 Q1	$1.9M	Buy	+43,126	New	+$2.05M	0.03%	209

Other funds holding ALKS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Geneva Advisors's ALKS Position: Q2 2014 in Review

Geneva Advisors sold out of Alkermes (ALKS) in Q2 2014, closing a stake of 43,126 shares — an estimated $1.9M sold.

Geneva Advisors first reported a position in ALKS in Q1 2014 and held it in 1 quarter. The position peaked at $1.9M in Q1 2014. 214 funds tracked by Wall St. Rank hold ALKS as of Q2 2014.

Geneva Advisors reported no remaining Alkermes position as of Q2 2014 after selling out during the quarter.
Geneva Advisors sold 43,126 Alkermes shares in Q2 2014, an estimated $1.9M.
Geneva Advisors first reported a position in Alkermes in Q1 2014 and held it in 1 quarter.
Geneva Advisors's Alkermes position peaked at $1.9M in Q1 2014.
214 funds tracked by Wall St. Rank held Alkermes as of Q2 2014.

Based on Geneva Advisors's 13F filing for Q2 2014, filed 7 Aug 2014.